PharmaLogic Executive and Leadership Team

Etienne Montagut, the President & Chief Executive Officer at PharmaLogic, directs the overarching strategy and operational execution for the global contract development and manufacturing organization. Montagut guides the company's expansion in diagnostic and therapeutic radiopharmaceuticals, leveraging a network of radiopharmacies and manufacturing facilities across North America and Europe. This leadership involves overseeing the development, manufacturing, and distribution of clinical and commercial radiopharmaceutical products, ensuring alignment with pharmaceutical partners and healthcare provider needs. The Chief Executive Officer's focus remains on driving innovation and market penetration within the specialized radiopharmaceutical sector. By fostering strategic partnerships and optimizing resource allocation, Etienne Montagut ensures PharmaLogic maintains its position as a key CDMO in the pharmaceutical landscape, contributing significantly to advancements in patient care through critical radiopharmaceutical supply chains.

Mark Dmytruk, the Chief Financial Officer at PharmaLogic, manages all financial operations and strategic financial planning for the global contract development and manufacturing organization. Dmytruk oversees budgeting, forecasting, and financial reporting, ensuring fiscal responsibility across the company's North American and European facilities. This role involves managing capital allocation, optimizing financial performance, and supporting strategic growth initiatives through robust financial analysis. The Chief Financial Officer plays a critical part in securing funding and managing investor relations, directly impacting the company's ability to expand its radiopharmaceutical development and manufacturing capabilities. By maintaining stringent financial controls and identifying key investment opportunities, Mark Dmytruk ensures PharmaLogic's sustained profitability and its capacity to serve pharmaceutical partners and healthcare providers effectively within the specialized radiopharmaceutical market.

Glen Palmer, the Chief Operating Officer at PharmaLogic, oversees the day-to-day operational execution and efficiency across the company's global network of radiopharmacies and manufacturing facilities. Palmer directs the complex processes involved in the development, manufacturing, and distribution of diagnostic and therapeutic radiopharmaceuticals, ensuring compliance with stringent industry regulations. This leadership role involves optimizing supply chain logistics, enhancing production capabilities, and driving operational excellence throughout North America and Europe. The Chief Operating Officer is instrumental in scaling operations to meet the growing demands of pharmaceutical partners and healthcare providers. By implementing best practices and fostering a culture of continuous improvement, Glen Palmer ensures the reliable and timely delivery of critical radiopharmaceutical products, directly supporting PharmaLogic's mission as a leading CDMO in the radiopharmaceutical sector.

Timothy Quinton, the President at PharmaLogic, drives strategic initiatives and commercial development for the global contract development and manufacturing organization, with a focus on expanding market reach for diagnostic and therapeutic radiopharmaceuticals. Quinton oversees key business development efforts, forging and strengthening relationships with pharmaceutical partners and healthcare providers across North America and Europe. This leadership position involves identifying new market opportunities and ensuring the effective distribution of radiopharmaceutical products. The President plays a vital role in translating the company's manufacturing capabilities into tangible commercial success, supporting the advancement of radiopharmaceutical therapies. By championing strategic growth and market penetration, Timothy Quinton ensures PharmaLogic remains at the forefront of the radiopharmaceutical CDMO sector, contributing to improved patient outcomes.

Pamela Wong, the Chief Legal Officer at PharmaLogic, provides comprehensive legal counsel and strategic guidance on all legal and regulatory matters affecting the global contract development and manufacturing organization. Wong oversees corporate governance, intellectual property protection, and contract negotiations with pharmaceutical partners and healthcare providers across North America and Europe. This critical role ensures compliance with all applicable laws and regulations governing the development, manufacturing, and distribution of radiopharmaceuticals. The Chief Legal Officer manages risk mitigation strategies and advises the executive team on legal implications of business decisions, safeguarding PharmaLogic's interests. By maintaining a strong legal framework, Pamela Wong supports the company's expansion and its commitment to ethical operations within the highly regulated radiopharmaceutical industry.

Hallie Pierson, the Chief People Officer at PharmaLogic, leads all human capital strategies and initiatives for the global contract development and manufacturing organization, focusing on talent acquisition, development, and retention across North America and Europe. Pierson designs and implements programs that foster a positive and productive work environment, essential for the specialized field of radiopharmaceutical manufacturing. This role involves overseeing compensation and benefits, employee relations, and organizational development to support the company's growth and operational objectives. The Chief People Officer ensures that PharmaLogic attracts and retains the highly skilled workforce necessary for developing, manufacturing, and distributing diagnostic and therapeutic radiopharmaceuticals. By cultivating a strong organizational culture, Hallie Pierson directly contributes to the company's ability to meet the complex needs of its pharmaceutical partners and healthcare providers.